Correctsequence's experimental gene-editing therapy CS-101 has been used to treat a person with SCD for the first time.

MAIA Biotechnology (MAIA) highlights efficacy data from its Phase 2 clinical trial, THIO-101, evaluating ateganosine sequenced with the immune ...

Detailed price information for Maia Biotechnology Inc (MAIA-A) from The Globe and Mail including charting and trades.

FDA grants orphan drug designation to BA-101, a promising treatment for glioblastoma, aiming to improve outcomes in this challenging cancer.

For the first time, a research team at the University of Minnesota Twin Cities demonstrated a groundbreaking process that combines 3D printing, stem cell biology, and lab-grown tissues for spinal cord ...

MAIA Biotechnology, Inc. ( ($MAIA) ) has provided an update. On September 11, 2025, MAIA Biotechnology announced positive efficacy data from its ...

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint ...

Dr. Ardem Patapoutian, PhD, is a recipient of the Nobel Prize in Physiology or Medicine in 2021 for his work characterizing the PIEZO1 and PIEZO2 receptors that detect touch, pressure, and ...

University of Minnesota researchers developed a 3D-printed scaffold that directs stem cells to grow into functioning nerve cells, successfully restoring movement in rats with severed spinal cords.

Lucy Shapiro received this year’s Lasker Special Achievement Award for her discovery of how bacteria use genetic circuits to ...